LYON, France, June 29, 2015 /PRNewswire/ --
MSD, known as Merck in the United States and Canada (NYSE: MRK) and Sanofi Pasteur, the
vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), the two
partner companies in Sanofi Pasteur MSD, announce today the
appointment of David Khougazian as president of Sanofi Pasteur
MSD.
To view the Multimedia News Release, please click:
http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur/
On July 1, Khougazian will join
Sanofi Pasteur MSD and effective September
1, will succeed Dr. Jean-Paul
Kress, who led the company since July
2011. Kress will leave Sanofi Pasteur MSD to join the Sanofi
group.
Video:
http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur/